Dr. MacArthur is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University Health Center Ste 7b
4201 St Antoine
Detroit, MI 48201Phone+1 313-745-4525
Education & Training
- Johns Hopkins UniversityFellowship, Infectious Disease, 1986 - 1988
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1983 - 1986
- University of Illinois College of MedicineClass of 1983
Certifications & Licensure
- GA State Medical License 2016 - 2026
- FL State Medical License 2018 - 2020
- MI State Medical License 1995 - 2017
- OH State Medical License 1985 - 2002
- MD State Medical License 1986 - 1997
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)
- A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination Start of enrollment: 2006 Mar 01
- Respiratory Virus Outpatient Study (FLU 002 Plus) Start of enrollment: 2009 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsCrofelemer, a novel agent for treatment of non-infectious diarrhea in HIV-infected personsPoorvi Chordia, Rodger D. MacArthur
Expert Review of Gastroenterology & Hepatology. 2013-09-01 - Overview of the XIX international AIDS conference.Rodger D. MacArthur
Current Infectious Disease Reports. 2013-02-01 - 4 citationsClinical Trial Report: TMC278 (Rilpivirine) Versus Efavirenz as Initial Therapy in Treatment-Naïve, HIV-1-Infected Patients.Rodger D. MacArthur
Current Infectious Disease Reports. 2011-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: